Neurofilament Light Chain And The New Era Of Brain Aging

What if the clearest signal about your brain’s future isn’t hidden inside an MRI, but floating in your blood right now? We dig into Neurofilament Light Chain (NFL), a nervous system biomarker that behaves like a smoke alarm for ongoing nerve damage and could help shift brain health from reactive to proactive.

We anchor the story in a remarkable study of 495 Japanese centenarians followed for up to 17 years. Researchers measured amyloid beta, phosphorylated tau, and NFL, and NFL came out on top for predicting cognitive function and mortality risk. That result forces a bigger rethink: clearing plaques may not be the same thing as slowing structural wear and tear across the brain and spinal cord, which helps explain why some Alzheimer’s drugs show modest cognitive benefits even when they hit their biological target.

From there, we break down the actual biology in plain language. Axons are long “cables,” NFL is part of their internal scaffolding, and when those cables degrade, NFL leaks into cerebrospinal fluid and then into the bloodstream. New ultrasensitive blood assays like Quanterix Simoa make it measurable without a spinal tap, opening the door to cheaper, repeatable tracking that can respond in weeks, not years.

We also get practical about how to use an NFL blood test wisely: why the trend line matters more than a single number, why you should avoid testing right after intense exercise, how obesity can falsely “lower” NFL via dilution, and which health factors tend to push NFL higher (sleep apnea, hypertension, diabetes, kidney disease, inflammation). We close with where this is heading next: tiered screening and “triggered prevention,” plus the open questions about baselines across different populations.

If you found this useful, subscribe, share it with someone who cares about brain health, and leave a review. What would you want to learn from your own NFL trajectory?

This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice. 

Never miss an episode—subscribe on your favorite podcast app!

Transcript

A Proactive Brain Health Shift

SPEAKER_01 0:00

So what if the secret to predicting your brain's future wasn't um locked away inside some massive $8,000 MRI tube, but was actually floating right now in the bloodstream of a 100-year-old.

SPEAKER_00 0:13

Yeah. It it's a completely wild thought. But today we are actually looking at a total paradigm shift in how we track biological aging.

SPEAKER_01 0:22

Right. Because for decades, I mean, the brain has basically been this black box. You kind of just had to wait until you started forgetting things to know something was wrong.

SPEAKER_00 0:29

Exactly. You're just waiting for the decline to become obvious. But for you listening right now, you know, the the learner who really wants to stay ahead of the curve, we are diving into a brand new toolkit today.

SPEAKER_01 0:40

Yeah. We are going to unpack a relatively unknown biomarker that could honestly do for your brain exactly what blood pressure and cholesterol panels did for your heart.

SPEAKER_00 0:49

We are finally moving from a reactive model of brain health to a proactive one. Instead of waiting for that cognitive decline, we now have this simple blood test.

SPEAKER_01 1:00

Just a blood test.

SPEAKER_00 1:01

Right. It's just a blood test that can reveal the precise rate at which your nervous system is taking damage. I mean, we spent the last half century building the preventative cardiology toolkit, and it completely revolutionized human longevity.

SPEAKER_01 1:15

And now neuroscience is kind of having that exact same moment.

SPEAKER_00 1:17

It

Centenarians And A New Biomarker

SPEAKER_00 1:18

really is.

SPEAKER_01 1:18

And to guide us through this moment, uh, our source material today is this truly fascinating Substack article. It was published in May 2026 by Dr. Kristen Glorioso, an MD PhD.

SPEAKER_00 1:30

Yeah. And the piece is titled A New Study in 495 Centenarians Points to a Brain-aging Biomarker you probably have not heard of.

SPEAKER_01 1:40

Okay, let's unpack this because to understand why this specific biomarker is suddenly making these massive waves, we have to look at a group of people who have already, well, essentially won the longevity lottery.

SPEAKER_00 1:51

The Japanese centenarian population, I mean, they offer the ultimate stress test for literally any aging theory.

SPEAKER_01 1:56

Because they've lived so long.

SPEAKER_00 1:58

Exactly. If you want to know what a resilient brain looks like, you don't study a 60-year-old. You study the people who have maintained their cognitive function way past the century mark.

SPEAKER_01 2:06

Right. So Dr. Glorioso highlights this major, highly anticipated study that was recently published in Jam and Network Open.

SPEAKER_00 2:14

It is an incredible data set.

SPEAKER_01 2:16

It really is. Researchers tracked 495 Japanese centenarians. So everyone is 100 years old or older, and they followed them for up to 17 years.

SPEAKER_00 2:26

Which is just staggering when you think about the logistics of that.

SPEAKER_01 2:29

Yeah, following someone who is already 100 for another 17 years. So at the beginning of the research, they drew blood and they measured three specific markers. Two of them are like the absolute kings of dementia research.

SPEAKER_00 2:41

Right, amyloid beta and phosphorylated tau.

SPEAKER_01 2:43

Yeah. Anyone who follows brain health knows those names. But they also measured a third marker, a protein called neurofilament light chain, which researchers just abbreviate as NFL. Trevor Burrus, Jr.

SPEAKER_00 2:54

And the data that emerged from comparing those three markers just completely upended the traditional hierarchy of neuroscience. Oh, totally. Because NFL radically outperformed both amyloid and tau in predicting cognitive function and overall lifespan. Wow. Yeah, the researchers found that for every one standard deviation increase in a centenarian's NFL levels, it actually corresponded to a staggering 36% higher mortality risk. Yes. And that correlation held completely firm even after they adjusted for age, sex, kidney function, like an entire panel of other health factors.

SPEAKER_01 3:30

Wait, I have to stop you there and push back a little on behalf of everyone listening.

SPEAKER_00 3:34

Sure.

SPEAKER_01 3:34

Because for 20 years, the dominant story about dementia has been entirely about amyloid plaques and tau tangles. Are you telling me this random, obscure NFL protein is a better predictor of your lifespan and brain trajectory than the literal established Alzheimer's markers?

SPEAKER_00 3:50

Aaron Powell If we connect this to the bigger picture, it actually exposes a major flaw in how we have been thinking about the brain for decades.

SPEAKER_01 3:57

How so?

SPEAKER_00 3:57

We will finally have these FDA-approved drugs, right, like Lotiganomab and Donamab.

SPEAKER_01 4:02

Right, the big blockbuster ones.

SPEAKER_00 4:03

Exactly. And they target and they successfully clear out those amyloid plaques. They do exactly what they were biologically designed to do. But the cognitive benefits for the actual patients taking them have been really modest at best.

SPEAKER_01 4:17

Because clearing the plaques doesn't just magically restore the brain.

SPEAKER_00 4:21

Exactly. Because Alzheimer's pathology isn't the whole story. Brain aging is cumulative. By the time someone reaches 100 years old, they don't just have one pure isolated disease pathway.

SPEAKER_01 4:34

Right, it's a mix of things.

SPEAKER_00 4:35

They have a lifetime of subtle overlapping pathologies. We're talking about the small vessel disease that quietly builds up from minor blood pressure fluctuations over the years.

SPEAKER_01 4:44

We're just basic cellular wear and tear.

SPEAKER_00 4:46

Yes, and the chronic simmering inflammation that just lingers after infections or metabolic stress. Amyloid markers only tell you about amyloid.

SPEAKER_01 4:53

Oh, I see.

SPEAKER_00 4:53

But NFL outperformed the others because it is capturing that entire broad spectrum of cumulative damage across the entire nervous system.

What NFL Measures In The Body

SPEAKER_01 5:01

Okay, so if NFL is the ultimate metric we should be paying attention to, we really need to understand what it actually is.

SPEAKER_00 5:06

Right, the actual biology.

SPEAKER_01 5:08

Yeah, because the biology here is just wild when you think about the physical scale of the nervous system. We all know that our nerves are made of axons, you know, these long transmission wires carrying electrical signals.

SPEAKER_00 5:18

But people forget these aren't just microscopic dots.

SPEAKER_01 5:21

Exactly. A single axon can run continuously from the base of your spinal cord all the way down to your foot. That is a single biological cable that can literally be an entire meter in length.

SPEAKER_00 5:34

And maintaining the structural integrity of a single cell that is a meter long requires some serious internal scaffolding.

SPEAKER_01 5:40

Yeah, it would just collapse otherwise.

SPEAKER_00 5:42

Right. So if you picture your nervous system as this vast network of suspension bridges, NFL is the steel cabling inside those bridges. It is the structural polymer that keeps those massive biological cables from collapsing under their own weight.

SPEAKER_01 5:56

If your nervous system is a network of suspension bridges, NFL is the steel cabling inside.

SPEAKER_00 6:01

Oh, I love that.

SPEAKER_01 6:01

So if you suddenly find a bunch of steel cables floating in the river below, you don't need to actually see the bridge to know it's taking structural damage.

SPEAKER_00 6:09

Exactly. The wreckage is right there in the water. So if your nervous system is taking damage, whether that is from a concussion or an autoimmune attack, or just the slow degradation of aging, those meter-long cells break open.

SPEAKER_01 6:24

And when they break those internal steel cables, the NFL fragments, they just leak out.

SPEAKER_00 6:28

They leak directly into the cerebrospinal fluid and eventually they wash into the general bloodstream. For a long time we couldn't really see the wreckage because the fragments in the blood were just way too small.

SPEAKER_01 6:38

But now we have the technology to see them.

SPEAKER_00 6:40

Right. We have these ultrasensitive blood assays that act like a microscopic net catching those minute fragments.

SPEAKER_01 6:45

And what's really fascinating is that this isn't just some weird human quirk. Dr. Matthias Jecker's group at the German Center for Neurodegenerative Diseases, they actually published a massive study in PLOS biology in February 2026.

SPEAKER_00 7:00

Oh, yeah, the animal study.

SPEAKER_01 7:01

Yeah. They looked at the blood of mice, dogs, cats, and horses. And in every single species, NFL rises with age and strongly predicts mortality.

SPEAKER_00 7:11

That evolutionary conservation is the ultimate proof that we're looking at something incredibly fundamental.

SPEAKER_01 7:16

Because it's across all these different animals.

SPEAKER_00 7:18

Right. When a biological mechanism is preserved across completely different mammalian species over literally millions of years of evolution, it proves this isn't just a marker for a specific human disease.

SPEAKER_01 7:31

It's a universal marker for the biological wear and tear of aging itself.

SPEAKER_00 7:35

Exactly. Dr. Glorioso uses a brilliant analogy in her substack, actually. She says NFL is a smoke detector for the nervous system.

SPEAKER_01 7:43

A smoke detector.

SPEAKER_00 7:44

Yeah. It doesn't tell you where the fire is in your house, and it doesn't tell you if the fire started from a candle or a frayed wire. It just tells you that nerve damage is actively happening, and the volume of the alarm tells you how fast the house

Fast Feedback For Concussions And MS

SPEAKER_00 7:57

is burning.

SPEAKER_01 7:57

Which brings us to the practical application of all this. Because knowing the biology is great, but for you, the listener, who just wants to stay sharp and healthy, how does this actually become a practical tool?

SPEAKER_00 8:08

Right. How do you use it?

SPEAKER_01 8:09

Yeah, because tracking brain aging usually feels agonizingly slow, like watching a glacier move.

SPEAKER_00 8:15

Well, the time scale is actually the first major advantage of NFL. Yeah. Unlike a cognitive test that might take literally years to show a measurable decline, NFL responds to injuries and interventions in a matter of weeks.

SPEAKER_01 8:27

Wow, weeks.

SPEAKER_00 8:28

We are already seeing sports medicine completely embrace this.

SPEAKER_01 8:31

Right, for concussions and return to play decisions.

SPEAKER_00 8:34

Exactly. After a traumatic brain injury, NFL levels in the plasma spike, and they peak anywhere from 10 days to six weeks out.

SPEAKER_01 8:43

So it's a physical metric, not just a guessing game.

SPEAKER_00 8:46

Right. Instead of a doctor just shining a light in a quarterback's eyes and asking, you know, how do you feel today? They can pull blood and say, your axons are still actively leaking structural proteins into your bloodstream.

SPEAKER_01 8:57

Your bridge is still broken.

SPEAKER_00 8:58

Yes, your bridge is broken. You cannot go back on the field yet. And we are seeing the exact same rapid feedback loop in multiple sclerosis clinical trials, too.

SPEAKER_01 9:06

Well, with the new drugs.

SPEAKER_00 9:07

Yeah. If a patient starts a new MS drug, the doctors can see if the treatment is stopping the autoimmune attack on the brain in just three to six months by watching the NFL levels drop.

SPEAKER_01 9:17

That rapid feedback is incredible. But I think the biggest practical shift for the average person is going to be the cost and just the accessibility of it.

SPEAKER_00 9:25

Oh, absolutely. The cost is a game changer.

SPEAKER_01 9:27

Historically, if you wanted to look at your brain's physical structure, you needed an MRI. And that is anywhere from $600 to $8,000.

SPEAKER_00 9:36

Not to mention the hassle.

SPEAKER_01 9:38

Exactly. You have to book a specialist. You have to lie perfectly still in this claustrophobic, noisy magnetic tube. And if you have a pacemaker or metal implants, you might just be out of luck entirely.

SPEAKER_00 9:49

But now we are talking about a direct-to-consumer blood test for roughly $200 to $400.

SPEAKER_01 9:56

And that accessibility completely changes how we approach preventative care, especially when you consider the breadth of what this test actually measures.

Cost, Access, And Trend Tracking

SPEAKER_00 10:05

Aaron Powell Because as we mentioned, NFL is nonspecific.

SPEAKER_01 10:08

But I have to ask, because usually in medicine, we want our test to be highly specific, right? We want a test that says you have disease X or you have disease Y. If the test is so broad that it can't diagnose a specific disease, why is that actually a good thing for the average person listening right now who just wants to stay sharp?

SPEAKER_00 10:25

Well, for a clinical diagnosis of a specific pathology, you absolutely want specificity. You need to know exactly what is wrong.

SPEAKER_01 10:32

Makes sense.

SPEAKER_00 10:33

But for tracking longitudinal wellness, breath is a massive feature.

SPEAKER_01 10:37

Because you want the big picture.

SPEAKER_00 10:39

Exactly. If you are a relatively healthy adult, you don't want to run 50 different specific assays every single year. You want a holistic metric.

SPEAKER_01 10:48

Just one number to look at.

SPEAKER_00 10:50

Right. NFL aggregates all the tiny insults your brain takes, you know, the poor sleep, the chronic stress, the minor hits to the head, the metabolic issues. It it aggregates all of that into one understandable continuous score.

SPEAKER_01 11:03

It's like the ultimate check engine light for your central nervous system.

SPEAKER_00 11:07

That is a perfect way to put it.

SPEAKER_01 11:08

But you can't just check it once and panic, right? Because the source is very clear that the real value of NFL is entirely about the trajectory over time, not just a single snapshot.

SPEAKER_00 11:17

Oh, yeah. A single high number on a Tuesday doesn't mean you are developing dementia. And a single low number doesn't mean you are totally invincible either.

SPEAKER_01 11:27

Because it changes naturally over time.

SPEAKER_00 11:29

Right. NFL levels naturally drift upward with age as a chronic baseline. In healthy populations, the background level of NFL roughly doubles between the ages of 30 and 70.

SPEAKER_01 11:41

Just from normal living.

SPEAKER_00 11:42

The background wear and tear simply increases over decades.

SPEAKER_01 11:46

So you have to interpret your results against an age-adjusted baseline.

SPEAKER_00 11:50

Exactly. What matters is the slope of the line over serial measurements.

SPEAKER_01 11:53

Right.

SPEAKER_00 11:54

Are you accelerating compared to your age group? Are you holding steady, or are you actually slowing down? The power is entirely in the trend.

SPEAKER_01 12:02

Which naturally brings us to the million-dollar question. Once you start tracking that trajectory, you obviously want to know how to control it.

SPEAKER_00 12:08

Everyone wants to push the number down.

What Raises Or Lowers NFL

SPEAKER_01 12:10

Exactly. What actually moves the needle on this biomarker? What raises it and what lowers it?

SPEAKER_00 12:15

Well, the chronic drivers that push NFL up are going to sound completely identical to the risk factors for a heart attack. Yeah. Age is obviously the primary factor. But beyond that, it is uncontrolled hypertension, diabetes, sleep apnea, chronic kidney disease, and long-standing low-grade inflammation.

SPEAKER_01 12:34

Aaron Powell Let's actually pause on sleep apnea for a second because I think a lot of people just view that as a snoring problem or an annoyance for their partner.

SPEAKER_00 12:42

It is so much more than that.

SPEAKER_01 12:43

How does something like sleep apnea physically damage the steel cables in your brain?

SPEAKER_00 12:48

When you have severe sleep apnea, you are repeatedly stopping breathing throughout the entire night.

SPEAKER_01 12:54

Right. You're choking basically.

SPEAKER_00 12:55

Yeah, this causes intermittent hypoxia. You're literally starving your brain of oxygen over and over again. And those massive meter-long biological cables require an immense amount of continuous energy just to maintain their structural integrity. Oh, so it's an energy crisis. Exactly. When you cut off the oxygen supply, the cells experience severe metabolic stress, the internal scaffolding begins to degrade, and the NFL leaks out. It's a mechanical breakdown caused by an energy deficit. And the same goes for hypertension, actually. High blood pressure constantly hammers the delicate microvasculature in the brain, causing tiny ruptures and starving local neurons of blood flow.

SPEAKER_01 13:33

Okay, so that covers the chronic slow burn damage. And then obviously there are the acute spikes, a stroke, a car accident, a sudden MS flare up.

SPEAKER_00 13:42

Right, the sudden massive fires.

SPEAKER_01 13:44

But what about putting the fire out? What actually lowers the smoke detector's alarm?

SPEAKER_00 13:48

The cleanest data we have so far comes from pharmaceutical interventions that successfully halt active nerve damage.

SPEAKER_01 13:54

Okay, like what?

SPEAKER_00 13:55

There is an ALS drug called Toferson. It's designed for a specific genetic form of Lugarig's disease. And in their clinical trials, it actually reduced plasma NFL by about 60% over 28 weeks.

SPEAKER_01 14:08

60%? That is a huge drop.

SPEAKER_00 14:11

It was a watershed moment in neuroscience because it was the first time the FDA accepted a blood biomarker like NFL as a surrogate endpoint to actually approve a neurological drug.

SPEAKER_01 14:21

Because the drug stopped the cables from breaking, so the blood markers plummeted.

SPEAKER_00 14:25

Exactly. We see the exact same success with modern MS drugs like ochrylazoomab two. They shut down the immune system's attack on the brain, and the NFL levels drop beautifully in tandem.

SPEAKER_01 14:36

But what if you aren't fighting ALS or MS? What if you're just a listener trying to optimize your brain health through daily habits?

SPEAKER_00 14:43

Aaron Powell Well the lifestyle data is still emerging, but there are some really strong signals already.

SPEAKER_01 14:47

Like with diet.

SPEAKER_00 14:48

Yeah. A 2024 trial of women with MS showed that strictly following a Mediterranean diet actually lowered their NFL levels over six months compared to a standard diet.

SPEAKER_01 14:58

Okay.

SPEAKER_00 14:59

And then a massive 2025 cohort of about 1,500 older adults showed significantly lower plasma NFL in people who adhered to mind or Mediterranean diets.

SPEAKER_01 15:09

Aaron Powell So food clearly matters. But here is where it gets really interesting. Yeah. The source points out two things that seem completely counterintuitive. And I demand an explanation for the listener.

SPEAKER_00 15:20

Okay, laid on me. Aaron Powell I know when you first read those two data points, it literally looks like a typo in the paper. But it perfectly illustrates why you have to really understand the physical mechanics of the test itself.

The Exercise Spike And Obesity Dilution

SPEAKER_01 15:39

Okay, let's take the exercise paradox first.

SPEAKER_00 15:41

Right. So when you engage in vigorous high-intensity exercise, you are putting your physical body under immense temporary stress.

SPEAKER_01 15:50

Sure. Your heart rate is up, you're sweating.

SPEAKER_00 15:53

Your core temperature rises, your metabolism redlines, and this actually causes a transient, totally harmless spike in NFL that leaks into the blood.

SPEAKER_01 16:02

Ah, so it's just from the temporary physical strain.

SPEAKER_00 16:05

Exactly. But it is strictly acute. The spike clears completely out of your system after about 72 hours.

SPEAKER_01 16:12

Okay.

SPEAKER_00 16:12

So the takeaway isn't that a hard workout causes brain damage. The takeaway is that you should never get your NFL drawn the morning after running a marathon, or your baseline will look falsely terrifying.

SPEAKER_01 16:23

Okay. That makes total sense. So it's purely a timing and temporary stress issue. But what about the obesity finding? How on earth does being heavily overweight lower a brain damage marker?

SPEAKER_00 16:33

The obesity factor is purely an issue of fluid dynamics. We call it the dilution effect.

SPEAKER_01 16:38

The dilution effect.

SPEAKER_00 16:39

Yeah. People with a significantly larger body mass simply have a much larger total volume of blood pumping through their circulatory system.

SPEAKER_01 16:47

Oh, I think I see where this is going.

SPEAKER_00 16:49

Imagine you have two people who both experience the exact same amount of brain damage, say a minor concussion.

SPEAKER_01 16:56

Okay.

SPEAKER_00 16:57

They both leak a hundred units of NFL protein. But the smaller person is leaking those hundred units into five liters of blood, while the obese person is leaking those same hundred units into eight liters of blood.

SPEAKER_01 17:09

The concentration is lower.

SPEAKER_00 17:11

Exactly. The assay measures the concentration of the protein per milliliter of liquid. So the blood test will read a falsely lower number for the obese patient, even though the underlying structural damage to the brain is identical. Wow. This is exactly why you cannot interpret raw numbers in a vacuum. You always have to adjust for BMI and clinical context.

SPEAKER_01 17:30

That makes perfect sense. And speaking of anomalies, Dr. Glorioso also notes some weird results with recent blockbuster drugs in her piece.

SPEAKER_00 17:38

Oh, right. Simaglutide and Lacanomab.

SPEAKER_01 17:40

Yeah, semaglutide, which everyone knows for weight loss, but was actually being tested for early Alzheimer's, saw NFL go up slightly in trials, and it ended up missing its cognitive endpoints.

SPEAKER_00 17:49

The Lacanamab too.

SPEAKER_01 17:51

Right. That FDA-approved amyloid drug we talked about earlier. It successfully cleared the Alzheimer's plaques, but it did not significantly reduce NFL in its pivotal trial.

SPEAKER_00 18:01

Which perfectly circles back to the lesson from the centenarian study we started with.

SPEAKER_01 18:06

How so?

SPEAKER_00 18:06

Well, if a drug like Lacanimab clears out the amyloid plaques, but it doesn't actually lower the rate of active nerve damage if the smoke detector is still blaring, the real world cognitive benefits for the patient are going to be severely limited.

SPEAKER_01 18:22

Because we were treating the plaque, but we weren't stopping the structural collapse of the bridge.

How To Get Tested And What’s Next

SPEAKER_00 18:26

Exactly.

SPEAKER_01 18:26

So if a listener wants to start tracking their own structural bridge, how do they get this test today? And where is this entire predictive field heading tomorrow?

SPEAKER_00 18:34

Well, the test is commercially available right now. Major labs in the U.S., like Lab Corp, you can actually ask your doctor for test number 140455.

SPEAKER_01 18:42

Oh wow, you have the actual test code.

SPEAKER_00 18:44

Yeah, and Quest Diagnostics offers it too. If you don't have a physician willing to order it, there are several direct-to-consumer CLIA certified labs offering it in that $200 to $400 range.

SPEAKER_01 18:57

And how do they measure something so small?

SPEAKER_00 18:59

To get the necessary sensitivity to find these tiny proteins in the blood, rather than the spinal fluid, they use a technology called quantarix Samoa.

SPEAKER_01 19:08

Samoa?

SPEAKER_00 19:09

Yeah, you can think of Samoa as a digital magnetic net that is so incredibly fine it can literally capture and count individual protein molecules floating in your plasma.

SPEAKER_01 19:19

That is wild.

SPEAKER_00 19:20

Dr. Glorioso also mentions her own company, actually, NeuroAge, which is pushing the envelope by measuring NFL at the RNA expression level alongside other modalities, though they aren't giving direct NFL consumer readouts just yet.

SPEAKER_01 19:32

Good to know. But the source does give a massive warning for anyone starting this journey.

SPEAKER_00 19:37

Yes, the lab consistency issue.

SPEAKER_01 19:39

Right. If you are going to track your NFL trajectory, you must stick to the exact same lab and the exact same platform year after year. Yeah, because if you get your baseline at Lab Corp and then switch to a different testing company next year, the baseline might ship simply because they use slightly different magnetic bead calibrations.

SPEAKER_00 19:57

And then your trajectory data just becomes completely useless.

SPEAKER_01 20:00

Exactly. So what does the future look like for this?

SPEAKER_00 20:03

Well, we are rapidly entering the era of biomarker trust prevention. We are no longer waiting for symptoms to show up.

SPEAKER_01 20:10

Triggered prevention.

SPEAKER_00 20:11

Yeah, the ATLACE trial for ALS and the Diane 2 trial for early onset Alzheimer's are already using this concept. They are actively monitoring patients with genetic risks. And the moment they see the NFL smoke detector go off, they trigger the start of heavy therapeutic treatments.

SPEAKER_01 20:29

Wow, so they are sending in the fire trucks before the patients ever show a single physical symptom of memory loss or muscle weakness.

SPEAKER_00 20:36

Exactly. And the ultimate goal for the general population is basically replacing the need for that expensive MRI entirely.

SPEAKER_01 20:43

That would be amazing.

SPEAKER_00 20:44

The article points to the Baltimore Longitudinal Study of Aging, which followed 622 cognitively unimpaired adults. Researchers are building predictive models that combine NFL with a few other plasma markers.

SPEAKER_01 20:57

Like what else?

SPEAKER_00 20:58

Like PTAW 181, which tracks Alzheimer-specific proteins, and GFAP, which tracks brain inflammation. By combining those blood markers, they can accurately predict longitudinal gray matter loss in the brain without ever needing to put the person in a scanner up front.

SPEAKER_01 21:15

So what does this all actually mean? Are we looking at a near future where my annual physical includes a simple $200 blood draw that tells my doctor I need an MRI rather than them just guessing based on my age?

SPEAKER_00 21:27

That is precisely the tiered screening pathway being built right now. It all goes back to the universal lesson from those 495 Japanese centenarians.

SPEAKER_01 21:35

Right, the longevity lottery winners.

SPEAKER_00 21:37

The individuals who successfully maintain their cognition to age 100 aren't just avoiding one specific disease. They're actively minimizing the overall structural wear and tear to their nervous system.

SPEAKER_01 21:48

So the biomarker that best predicts cognitive survival is the one that captures the broadest range of that structural damage.

SPEAKER_00 21:55

Exactly. That is why NFL is going to become the center of clinical preventive neurodiscalogy.

SPEAKER_01 22:00

It really is a profound shift in how we view aging. To quickly recap the journey we've taken today for you listening, we are moving away from a world where brain health was this impenetrable black box, measured only by waiting for memory loss or relying solely on highly specific Alzheimer's markers.

SPEAKER_00 22:18

Right, we are moving past just amyloid and tau.

SPEAKER_01 22:21

Exactly. We now have a universal smoke detector for overall brain aging. It's a structural scaffolding protein called NFL that leaks into your blood when your massive neural cables take damage.

SPEAKER_00 22:33

And for just a couple hundred dollars, you can establish your baseline today.

SPEAKER_01 22:36

Yeah, and you can track your brain's trajectory over time, giving you the power to actually see if your sleep, your diet, and your lifestyle interventions are putting out the fire.

SPEAKER_00 22:45

It is an incredibly empowering piece of knowledge to have in your personal toolkit.

SPEAKER_01 22:49

It really is.

Open Questions And Final Takeaways

SPEAKER_00 22:50

But to leave you with something to truly mull over, I want to highlight a brilliant, slightly provocative point raised in the comment section of Dr. Glorioso's Substack by a reader named Drew Despero.

SPEAKER_01 23:02

Oh, yeah, the comment section had some great insights.

SPEAKER_00 23:05

He brings up two vital questions that the scientific community still has to reckon with as this test goes mainstream. First, the incredible baseline data we discussed came from a highly specific genetically and culturally homogeneous population Japanese centenarians.

SPEAKER_01 23:20

Right.

SPEAKER_00 23:21

As we roll this test out globally, we have to ask: does this exact mortality trajectory hold true across entirely different Western diets, different environmental toxins, and diverse genetic backgrounds?

SPEAKER_01 23:32

That is a massive variable that still needs solving.

SPEAKER_00 23:35

And second, he asks a deeply philosophical medical question. Is a rising NFL level truly predicting a future disease that hasn't happened yet? Or is it simply the earliest possible mirror reflecting a disease that has already secretly taken hold of the brain?

unknown 23:50

Wow.

SPEAKER_00 23:50

It completely challenges how we define the beginning of neurodegeneration itself.

SPEAKER_01 23:54

That is a fascinating thought to leave on. I mean, if the X-ray shows the broken bone, NFL shows the microscopic stress fractures happening years before the break.

SPEAKER_00 24:03

Beautifully said.

SPEAKER_01 24:04

It might still be slightly murky waters right now, but at least we finally have a flashlight to see through the mud. Thank you for joining us on this deep dive. Keep asking questions, keep tracking your trajectory, and most importantly, stay curious.